ERGIC1 Antikörper (AA 42-290)

Produktnummer ABIN7601690

Dieses Anti-ERGIC1-Antikörper ist ein Kaninchen Polyklonal-Antikörper zur Detektion von ERGIC1 in ELISA, WB und FACS. Geeignet für Human, Maus und Ratte.

Kurzübersicht für ERGIC1 Antikörper (AA 42-290) (ABIN7601690)

Target: ERGIC1 (Endoplasmic Reticulum-Golgi Intermediate Compartment (ERGIC) 1 (ERGIC1))

Reaktivität: Human, Maus, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser ERGIC1 Antikörper ist unkonjugiert

Applikation: ELISA, Western Blotting (WB), Flow Cytometry (FACS)

Produktdetails anti-ERGIC1 Antikörper

Bindungsspezifität: AA 42-290

Verwendungszweck: Anti-ERGIC1 Antibody Picoband®

Kreuzreaktivität (Details): No cross-reactivity with other proteins.

Produktmerkmale: Anti-ERGIC1 Antibody Picoband® (ABIN7601690). Tested in ELISA, Flow Cytometry, WB applications. This antibody reacts with Human, Mouse, Rat. The brand Picoband indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as Picoband, ensuring unmatched performance.

Aufreinigung: Immunogen affinity purified.

Immunogen: E.coli-derived human ERGIC1 recombinant protein (Position: S42-H290).

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Western blot, 0.25-0.5 μg/mL, Human, Mouse, Rat
Flow Cytometry (Fixed), 1-3 μg/1x10⁶ cells, Human
ELISA, 0.1-0.5 μg/mL, -
1. Breuza, L., Halbeisen, R., Jeno, P., Otte, S., Barlowe, C., Hong, W., Hauri, H.-P. Proteomics of endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membranes from brefeldin A-treated HepG2 cells identifies ERGIC-32, a new cycling protein that interacts with human Erv46. J. Biol. Chem. 279: 47242-47253, 2004. 2. Lebenthal, E., Shochet, S. B., Adam, A., Seelenfreund, M., Fried, A., Najenson, T., Sandbank, U., Matoth, Y. Arthrogryposis multiplex congenita--23 cases in an Arab kindred. Pediatrics 46: 891-899, 1970. 3. Reinstein, E., Drasinover, V., Lotan, R., Gal-Tanamy, M., Nachman, I. B., Eyal, E., Jaber, L., Magal, N., Shohat, M. Mutations in ERGIC1 cause arthrogryposis multiplex congenita, neuropathic type. Clin. Genet. 93: 160-163, 2018.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL.

Konzentration: 500 μg/mL

Buffer: Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: At -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freezing and thawing.

Details zu ERGIC1

Target: ERGIC1 (Endoplasmic Reticulum-Golgi Intermediate Compartment (ERGIC) 1 (ERGIC1))

Andere Bezeichnung: ERGIC1

Hintergrund:

Synonyms: Interleukin-17B, IL-17B, Cytokine CX1, Cytokine-like protein ZCYTO7, Neuronal interleukin-17-related factor, Il17b, Nirf, Zcyto7

Tissue Specificity: Expressed in adult pancreas, small intestine, stomach, spinal cord and testis. Less pronounced expression in prostate, colon mucosal lining, and ovary.

Background: This gene encodes a cycling membrane protein which is an endoplasmic reticulum-golgi intermediate compartment (ERGIC) protein which interacts with other members of this protein family to increase their turnover.

Molekulargewicht: 35 kDa

Gen-ID: 57222

UniProt: Q969X5

Pathways: SARS-CoV-2 Protein Interaktom